Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 2.36 USD -7.45% Market Closed
Market Cap: 108.5m USD

Intrinsic Value

KRMD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one KRMD stock under the Base Case scenario is 2.62 USD. Compared to the current market price of 2.36 USD, Repro Med Systems Inc is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRMD Intrinsic Value
2.62 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Repro Med Systems Inc

KRMD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for KRMD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Repro Med Systems Inc
NASDAQ:KRMD
US
Health Care
Market Cap
108.5m USD
IPO
Oct 27, 1993
US
Health Care
Market Cap
108.5m USD
IPO
Oct 27, 1993
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KRMD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Repro Med Systems Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Repro Med Systems Inc

Current Assets 19.1m
Cash & Short-Term Investments 9.6m
Receivables 6m
Other Current Assets 3.6m
Non-Current Assets 8.1m
PP&E 7.3m
Intangibles 730.3k
Other Non-Current Assets 98.9k
Efficiency

Free Cash Flow Analysis
Repro Med Systems Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Repro Med Systems Inc

Revenue
33.6m USD
Cost of Revenue
-12.3m USD
Gross Profit
21.3m USD
Operating Expenses
-27.8m USD
Operating Income
-6.4m USD
Other Expenses
379.6k USD
Net Income
-6.1m USD
Fundamental Scores

KRMD Profitability Score
Profitability Due Diligence

Repro Med Systems Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
Declining ROIC
23/100
Profitability
Score

Repro Med Systems Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

KRMD Solvency Score
Solvency Due Diligence

Repro Med Systems Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
69/100
Solvency
Score

Repro Med Systems Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRMD Price Targets Summary
Repro Med Systems Inc

Wall Street analysts forecast KRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRMD is 5.81 USD with a low forecast of 4.55 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.55 USD
93% Upside
Average
Price Target
5.81 USD
146% Upside
Highest
Price Target
7.35 USD
211% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Repro Med Systems Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KRMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KRMD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KRMD stock?

The intrinsic value of one KRMD stock under the Base Case scenario is 2.62 USD.

Is KRMD stock undervalued or overvalued?

Compared to the current market price of 2.36 USD, Repro Med Systems Inc is Undervalued by 10%.

Back to Top